Aethlon Medical shareholders reject proposal to authorize 20 million preferred shares
Aethlon Medical shareholders rejected a proposal to authorize 20,000,000 shares of preferred stock. The company filed an amended 8-K to correct a prior disclosure, stating the proposal failed to pass as only 204,122 shares voted for it, below the required majority.